This startup is developing a test to detect early-stage ovarian cancer

When treating cancer, the earliest possible detection often yields the greatest chance of successful treatment.

Statistics indicate that’s especially true of ovarian cancer, which causes more deaths than any other cancer of the female reproductive system. But there’s a problem.

“There is not a good way to detect early-stage ovarian cancer,” said Howie Kaufman. “It presents in later stages when it’s more difficult to treat successfully.”

As CEO of PapGene, Kaufman is leading an effort to commercialize a test that is targeting the earliest stage of the cancer.

Read more at Technical.ly Baltimore

from http://baltimoretech.org/news/this-startup-is-developing-a-test-to-detect-early-stage-ovarian-cancer/